A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
Clinical trial NCT03347188 · COMPLETED
Trial details
- NCT number
- NCT03347188
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2020-03-13
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.